Literature DB >> 20635391

Functional analysis of bispecific antibody (EpCAMxCD3)-mediated T-lymphocyte and cancer cell interaction by single-cell force spectroscopy.

Sabrina C Hoffmann1, Guido H Wabnitz, Yvonne Samstag, Gerhard Moldenhauer, Thomas Ludwig.   

Abstract

The atomic force microscopy (AFM) is a powerful tool to analyze forces generated on cellular interactions on the single-cell level. This highly sensitive device can record changes in force in the pico-Newton range, which equals single molecule bonds. Here, we have used single-cell force spectroscopy by AFM to investigate the interaction between T cells and tumor cells that is induced by the bispecific antibody HEA125xOKT3 (specificity anti-EpCAMxCD3). We show that HEA125xOKT3 induces a specific increase in adhesion force between T cells and cancer cells. The adhesive force that is generated on cell-cell contact is dependent on the applied force on initial contact and the duration of this initial contact. In summary, HEA125xOKT3 has been found to mediate contact formation by distinct processes. It induces direct cell-cell interaction, which results in the activation of T-cell signaling, facilitates the formation of supramolecular activation clusters and ultimately of an immune synapse.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20635391     DOI: 10.1002/ijc.25556

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

Review 1.  T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics.

Authors:  Z Wu; N V Cheung
Journal:  Pharmacol Ther       Date:  2017-08-20       Impact factor: 12.310

2.  Combining forces to hit cancer stem cells: TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancer.

Authors:  Ingrid Herr; Ariane Groth; Alexei V Salnikov; Markus W Büchler; Gerhard Moldenhauer
Journal:  Oncoimmunology       Date:  2012-08-01       Impact factor: 8.110

Review 3.  Recent advances of bispecific antibodies in solid tumors.

Authors:  Shengnan Yu; Anping Li; Qian Liu; Xun Yuan; Hanxiao Xu; Dechao Jiao; Richard G Pestell; Xinwei Han; Kongming Wu
Journal:  J Hematol Oncol       Date:  2017-09-20       Impact factor: 17.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.